[The possibility of selective chemotherapy of progressive recurring ovarian carcinoma with the aid of cytodiagnosis and incorporation of tagged idoxuridine].
D000368:Aged; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use; D001201:Ascites; D003520:Cyclophosphamide / Q000378:metabolism; D003581:Cytodiagnosis; D005260:Female; D006801:Humans; D007065:Idoxuridine / Q000378:metabolism*; D007456:Iodine Isotopes; D008727:Methotrexate / Q000378:metabolism; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009360:Neoplastic Cells, Circulating; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D013997:Time Factors
D000970:Antineoplastic Agents; D007456:Iodine Isotopes; D003520:Cyclophosphamide; D007065:Idoxuridine; D008727:Methotrexate
Die Möglichkeit einer gezielten Chemotherapie des fortgeschrittenen rezidivierenden Ovarialkarzinoms mit Hilfe der Zytodiagnostik und der Inkorporation von markiertem Jododeoxyuridine.